Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Cash flows from operating activities:
Net income	$ 14,618,450	$ 10,958,481
Adjustments to reconcile net income to net cash used in operating activities:
Amortization (accretion) of investments	(32,084)	163,471
Realized investment gains, net	(6,415,476)	(649,446)
Change in fair value of equity securities	(14,884,779)	(15,360,956)
Amortization of cost of insurance acquired	387,953	403,033
Depreciation	594,399	572,751
Stock-based compensation	246,534	246,757
Charges for mortality and administration of universal life and annuity products	(3,235,159)	(3,304,604)
Interest credited to account balances	2,052,343	2,119,747
Change in accrued investment income	140,588	131,976
Change in reinsurance receivables	338,491	469,778
Change in policy liabilities and accruals	(1,317,789)	(658,483)
Change in income taxes receivable (payable)	(25,242)	6,177
Change in other assets and liabilities, net	2,842,382	6,438,057
Net cash provided by (used in) operating activities	(4,689,389)	1,536,739
Proceeds from investments sold and matured:
Fixed maturities available for sale	4,566,651	12,881,864
Equity securities	4,939,893	716,323
Mortgage loans	4,381,319	2,240,015
Real estate	10,687,242	9,472,966
Notes receivable	1,827,987	824,062
Policy loans	930,639	1,087,790
Short-term investments	0	2,114,000
Total proceeds from investments sold and matured	27,333,731	29,337,020
Cost of investments acquired:
Fixed maturities available for sale	(2,507,805)	(15,304,506)
Equity securities	(115,013)	(9,010,290)
Trading securities	(132,518)	0
Mortgage loans	(4,014,455)	0
Real estate	(1,408,021)	(8,420,117)
Notes receivable	(7,528,188)	(4,000,000)
Policy loans	(705,906)	(960,620)
Short-term investments	0	(2,114,000)
Total cost of investments acquired	(16,411,906)	(39,809,533)
Net cash provided by (used in) investing activities	10,921,825	(10,472,513)
Cash flows from financing activities:
Policyholder contract deposits	2,410,517	2,426,333
Policyholder contract withdrawals	(2,756,026)	(3,569,583)
Purchase of treasury stock	(561,342)	(953,419)
Non controlling contributions (distributions) of consolidated subsidiary	(245,750)	(247,592)
Net cash used in financing activities	(1,152,601)	(2,344,261)
Net increase (decrease) in cash and cash equivalents	5,079,835	(11,280,035)
Cash and cash equivalents at beginning of period	20,150,162	25,434,199
Cash and cash equivalents at end of period	$ 25,229,997	$ 14,154,164